Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0000914475-24-000078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-22 | 2024-02-20 | NBIX | POPS RICHARD F | Dir | S - Sale+OE | $132.47 | -15.0K | 29.5K | -34% | -$1.99M |
| D | 2024-02-22 | 2024-02-20 | NBIX | POPS RICHARD F | Dir | M - OptEx | $12.98 | +15.0K | 44.5K | +51% | +$194.7K |
| D | 2024-02-22 | 2024-02-20 | NBIX | POPS RICHARD F | Dir | M - OptEx | $12.98 | -15.0K | 0 | -100% | -$194.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | S | D | 15,000 | $132.47 | 29,512 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.64 to $134.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Stock | 2024-02-20 | M | A | 15,000 | $12.98 | 44,512 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option | 2024-02-20 | M | D | 15,000 | $12.98 | 0 | D | $12.98 · — to 2024-05-22 | 15,000 Common Stock | (F3) The option was granted May 22, 2014 and vested in 12 equal monthly installments beginning June 22, 2014. These options will expire ten years from the date of grant on May 22, 2024. |